Publication date: Aug 01, 2025
The association between circulating vitamin D levels and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza infection in vaccine recipients remains unclear. We prospectively examined these associations among healthcare workers. This study included 1434 staff members at a tertiary hospital who completed a questionnaire and provided blood samples in December 2023. Participants were followed for SARS-CoV-2 and seasonal influenza infections until March 2024, based on data from an in-house registry and responses to a follow-up questionnaire. Baseline serum 25-hydroxyvitamin D levels were categorized as sufficient (≥20 ng/mL), insufficient (12-19 ng/mL), or deficient (
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Vitamin D |
| pathway | REACTOME | Influenza Infection |
| drug | DRUGBANK | Etoperidone |
| disease | IDO | blood |
| disease | MESH | influenza |
| disease | MESH | infections |
| disease | MESH | COVID-19 |
| disease | MESH | Vitamin D Deficiency |